Therapeutic Areas

Our expertise in these niche, narrow-field therapeutic areas drives innovation and faster drug launches across our European territories.

Genetic & Metabolic Disorders

Our commercialisation expertise spans a range of genetic & metabolic disorders and conditions.

Haematology & Oncology

Within haematology, we work with products and therapies serving a handful of key rare diseases.

CNS & Neurology

Our experience also extends to rare, hereditary disorders affecting the central nervous system.

“Working with rare diseases is immensely meaningful to us. We advocate for patients with often overlooked conditions and high unmet medical needs, and our goal is to ensure they have access to innovative and essential treatments. This mission holds profound meaning for our team and drives our dedication every day.”

Latest articles

Pharma commercialization strategies: A blueprint for launching a new product in Europe
Medical affairs challenges for orphan drugs: the key to a winning KOL engagement strategy
How real-world evidence is changing Health Technology Assessment (HTA) submissions